| UniProt ID | IKIP_HUMAN | |
|---|---|---|
| UniProt AC | Q70UQ0 | |
| Protein Name | Inhibitor of nuclear factor kappa-B kinase-interacting protein | |
| Gene Name | IKBIP | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 350 | |
| Subcellular Localization |
Endoplasmic reticulum membrane Single-pass membrane protein . Isoform 4 deletion of the hydrophobic, or transmembrane region between AA 45-63 results in uniform distribution throughout the cell, suggesting that this region is responsible for endopl |
|
| Protein Description | Target of p53/TP53 with pro-apoptotic function.. | |
| Protein Sequence | MSEVKSRKKSGPKGAPAAEPGKRSEGGKTPVARSSGGGGWADPRTCLSLLSLGTCLGLAWFVFQQSEKFAKVENQYQLLKLETNEFQQLQSKISLISEKWQKSEAIMEQLKSFQIIAHLKRLQEEINEVKTWSNRITEKQDILNNSLTTLSQDITKVDQSTTSMAKDVGLKITSVKTDIRRISGLVTDVISLTDSVQELENKIEKVEKNTVKNIGDLLSSSIDRTATLRKTASENSQRINSVKKTLTELKSDFDKHTDRFLSLEGDRAKVLKTVTFANDLKPKVYNLKKDFSRLEPLVNDLTLRIGRLVTDLLQREKEIAFLSEKISNLTIVQAEIKDIKDEIAHISDMN | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 10 | Phosphorylation | EVKSRKKSGPKGAPA CHHCCCCCCCCCCCC | 64.46 | 24719451 | |
| 13 | Ubiquitination | SRKKSGPKGAPAAEP CCCCCCCCCCCCCCC | 71.83 | 33845483 | |
| 22 | Ubiquitination | APAAEPGKRSEGGKT CCCCCCCCCCCCCCC | 64.56 | 33845483 | |
| 24 | Phosphorylation | AAEPGKRSEGGKTPV CCCCCCCCCCCCCCC | 44.04 | 25159151 | |
| 28 | Ubiquitination | GKRSEGGKTPVARSS CCCCCCCCCCCCCCC | 61.59 | 24816145 | |
| 76 | Phosphorylation | FAKVENQYQLLKLET HHHHHHHHHHHHHCC | 16.83 | - | |
| 80 | Ubiquitination | ENQYQLLKLETNEFQ HHHHHHHHHCCCHHH | 53.52 | 29967540 | |
| 92 | Ubiquitination | EFQQLQSKISLISEK HHHHHHHHHHHHCHH | 24.29 | 21963094 | |
| 92 (in isoform 4) | Ubiquitination | - | 24.29 | - | |
| 92 | 2-Hydroxyisobutyrylation | EFQQLQSKISLISEK HHHHHHHHHHHHCHH | 24.29 | - | |
| 97 | Phosphorylation | QSKISLISEKWQKSE HHHHHHHCHHHHHHH | 38.12 | 24719451 | |
| 99 | Acetylation | KISLISEKWQKSEAI HHHHHCHHHHHHHHH | 48.40 | 27452117 | |
| 103 | Phosphorylation | ISEKWQKSEAIMEQL HCHHHHHHHHHHHHH | 19.70 | 30622161 | |
| 144 | N-linked_Glycosylation | TEKQDILNNSLTTLS HHHHHHHHCHHHHHH | 36.06 | 19159218 | |
| 160 | Phosphorylation | DITKVDQSTTSMAKD CHHHCCHHHHHHHHH | 29.23 | 29759185 | |
| 161 | Phosphorylation | ITKVDQSTTSMAKDV HHHCCHHHHHHHHHH | 19.77 | 29759185 | |
| 162 | Phosphorylation | TKVDQSTTSMAKDVG HHCCHHHHHHHHHHC | 23.04 | 29759185 | |
| 163 | Phosphorylation | KVDQSTTSMAKDVGL HCCHHHHHHHHHHCC | 19.48 | 22210691 | |
| 173 | Phosphorylation | KDVGLKITSVKTDIR HHHCCEEEECHHHHH | 26.36 | 29759185 | |
| 174 | Phosphorylation | DVGLKITSVKTDIRR HHCCEEEECHHHHHH | 25.70 | 29759185 | |
| 183 | Phosphorylation | KTDIRRISGLVTDVI HHHHHHHHCHHHHHH | 25.02 | - | |
| 187 | Phosphorylation | RRISGLVTDVISLTD HHHHCHHHHHHHHHH | 29.59 | - | |
| 191 | Phosphorylation | GLVTDVISLTDSVQE CHHHHHHHHHHHHHH | 25.68 | - | |
| 193 | Phosphorylation | VTDVISLTDSVQELE HHHHHHHHHHHHHHH | 21.31 | - | |
| 203 | Ubiquitination | VQELENKIEKVEKNT HHHHHHHHHHHHHHH | 10.51 | 29967540 | |
| 212 | Ubiquitination | KVEKNTVKNIGDLLS HHHHHHHCCHHHHHH | 40.59 | - | |
| 219 | Phosphorylation | KNIGDLLSSSIDRTA CCHHHHHHHHHCCHH | 29.36 | 21712546 | |
| 220 | Phosphorylation | NIGDLLSSSIDRTAT CHHHHHHHHHCCHHH | 31.14 | 21712546 | |
| 221 | Phosphorylation | IGDLLSSSIDRTATL HHHHHHHHHCCHHHH | 25.73 | - | |
| 225 | Phosphorylation | LSSSIDRTATLRKTA HHHHHCCHHHHHHHH | 21.90 | - | |
| 236 | Ubiquitination | RKTASENSQRINSVK HHHHHHHHHHHHHHH | 19.45 | 32015554 | |
| 240 | Ubiquitination | SENSQRINSVKKTLT HHHHHHHHHHHHHHH | 42.83 | 29967540 | |
| 241 | Phosphorylation | ENSQRINSVKKTLTE HHHHHHHHHHHHHHH | 32.70 | 24719451 | |
| 247 | Phosphorylation | NSVKKTLTELKSDFD HHHHHHHHHHHHHHH | 44.49 | - | |
| 258 | Ubiquitination | SDFDKHTDRFLSLEG HHHHHCHHHHHHCCC | 38.77 | 29967540 | |
| 281 | Acetylation | VTFANDLKPKVYNLK HHCCCCCCHHHCCCC | 45.73 | 27452117 | |
| 295 | Ubiquitination | KKDFSRLEPLVNDLT CCCHHHHHHHHHHHH | 35.16 | 32015554 | |
| 317 | 2-Hydroxyisobutyrylation | TDLLQREKEIAFLSE HHHHHHHHHHHHHHH | 57.52 | - | |
| 328 | N-linked_Glycosylation | FLSEKISNLTIVQAE HHHHHHHCCEEEEHH | 44.68 | 19159218 | |
| 330 (in isoform 4) | Phosphorylation | - | 24.29 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of IKIP_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference |
|---|---|---|---|---|
| 154 | N | Glycosylation |
| 31953408 |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of IKIP_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| N-linked Glycosylation | |
| Reference | PubMed |
| "Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-144 AND ASN-328, AND MASSSPECTROMETRY. | |